Sex differences in ERβ, CXCL12, and CXCR4 expression have also been demonstrated in lung adenocarcinomas, with tumors from premenopausal women having greater expression than tumors from postmenopausal women and men (Figure 2A) [151]. Here, ESR2 is linked to lung adenocarcinoma.